$3.78 -0.09 (-2.33%)
11/27/2009 1:00 PM

GTx, Inc. (GTXI)

CAPS Rating: 3 out of 5

A biopharmaceutical company dedicated to the discovery, development & commercialization of small molecules that selectively target hormone pathways to treat cancer, osteoporosis & bone loss, muscle wasting & other serious medical conditions.

Featured Broker Partners